Welcome to our dedicated page for Beyond SEC filings (Ticker: BYON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Beyond Inc.'s SEC filings document operating results, material events, governance matters, shareholder voting matters, and capital-structure disclosures for an ecommerce retail issuer with common stock and warrants. The records include reports filed under the Bed Bath & Beyond, Inc. name and cover the company's Bed Bath & Beyond, Overstock, buybuy BABY, Kirkland's and Kirkland's Home brands, related websites, and blockchain asset portfolio.
Recent filings include Form 8-K and 8-K/A disclosures for financial results, material definitive agreements, completed acquisition activity, and references to Form S-4 registration materials and joint proxy/prospectus filings. They also document the completed acquisition of The Brand House Collective, shareholder-vote matters, securities issued in transactions, and governance and capital-structure changes affecting the retail brand portfolio.
Bed Bath & Beyond director Robert Jacob Shapiro increased his equity stake through compensation-related stock transactions. On May 15, 2026, 26,873 restricted stock units vested and were converted into the same number of common shares at no cost, bringing his direct common stock holdings to 67,107 shares.
On May 14, 2026, he received a new award of 35,181 restricted stock units, each representing a right to one future common share that vests on May 14, 2027. He also holds 4,022 common stock warrants, each allowing the purchase of one share at an exercise price of $15.50 per share, originally distributed pro rata to all common stockholders in October 2025.
Bed Bath & Beyond director Robert Jacob Shapiro increased his equity stake through compensation-related stock transactions. On May 15, 2026, 26,873 restricted stock units vested and were converted into the same number of common shares at no cost, bringing his direct common stock holdings to 67,107 shares.
On May 14, 2026, he received a new award of 35,181 restricted stock units, each representing a right to one future common share that vests on May 14, 2027. He also holds 4,022 common stock warrants, each allowing the purchase of one share at an exercise price of $15.50 per share, originally distributed pro rata to all common stockholders in October 2025.
Bed Bath & Beyond director Joanna M. Burkey reported compensation-related equity activity. On May 15, 2026, 26,873 restricted stock units vested and were delivered as common shares, bringing her directly held common stock to 42,417 shares. The day before, she received a new grant of 35,181 restricted stock units that vest on May 14, 2027. She also holds 1,554 common stock warrants, each exercisable for one share at an exercise price of $15.50, from a pro-rata distribution originally issued on October 7, 2025.
Bed Bath & Beyond director Joanna M. Burkey reported compensation-related equity activity. On May 15, 2026, 26,873 restricted stock units vested and were delivered as common shares, bringing her directly held common stock to 42,417 shares. The day before, she received a new grant of 35,181 restricted stock units that vest on May 14, 2027. She also holds 1,554 common stock warrants, each exercisable for one share at an exercise price of $15.50, from a pro-rata distribution originally issued on October 7, 2025.
Bed Bath & Beyond director Debra Golding Perelman reported equity compensation activity, acquiring shares through RSU vesting and receiving new awards. On May 15, 2026, 26,873 restricted stock units converted into the same number of common shares at a price of $0.00, increasing her direct common stock holdings to 32,174 shares.
On May 14, 2026, she received a grant of 35,181 restricted stock units, each representing a contingent right to one common share that vests at the close of business on May 14, 2027. She also holds 530 common stock warrants that were originally issued on October 7, 2025 in a pro-rata distribution to all common shareholders, each exercisable for one common share at an exercise price of $15.50 per warrant until October 7, 2026.
Bed Bath & Beyond director Debra Golding Perelman reported equity compensation activity, acquiring shares through RSU vesting and receiving new awards. On May 15, 2026, 26,873 restricted stock units converted into the same number of common shares at a price of $0.00, increasing her direct common stock holdings to 32,174 shares.
On May 14, 2026, she received a grant of 35,181 restricted stock units, each representing a contingent right to one common share that vests at the close of business on May 14, 2027. She also holds 530 common stock warrants that were originally issued on October 7, 2025 in a pro-rata distribution to all common shareholders, each exercisable for one common share at an exercise price of $15.50 per warrant until October 7, 2026.
Bed Bath & Beyond director Joseph J. Tabacco Jr. reported compensation-related equity activity. On May 15, 2026, restricted stock units covering 26,873 shares of common stock vested and were converted into the same number of common shares, increasing his directly held stock.
On May 14, 2026, he also received a new grant of 35,181 restricted stock units, each representing a contingent right to one share of common stock that will vest on May 14, 2027. After these transactions, he holds 38,379 common shares directly, plus 167,209 common shares indirectly held by the Joseph Tabacco and Peggy Schmidt Revocable Trust, along with 35,181 RSUs from the new grant.
Bed Bath & Beyond director Joseph J. Tabacco Jr. reported compensation-related equity activity. On May 15, 2026, restricted stock units covering 26,873 shares of common stock vested and were converted into the same number of common shares, increasing his directly held stock.
On May 14, 2026, he also received a new grant of 35,181 restricted stock units, each representing a contingent right to one share of common stock that will vest on May 14, 2027. After these transactions, he holds 38,379 common shares directly, plus 167,209 common shares indirectly held by the Joseph Tabacco and Peggy Schmidt Revocable Trust, along with 35,181 RSUs from the new grant.
LEMONIS MARCUS reported acquisition or exercise transactions in this Form 4 filing.
Bed Bath & Beyond, Inc. executive chairman and CEO Marcus Lemonis received a grant of 1,500,000 restricted stock units, each representing a contingent right to one share of common stock. The grant was approved by shareholders on May 14, 2026, after being originally granted on March 11, 2026.
The restricted stock units vest in four equal installments at the close of business on January 1, 2027, January 1, 2028, January 1, 2029, and January 1, 2030, with vested shares delivered promptly after each vesting date. Following this transaction, Lemonis is shown as beneficially owning 1,500,000 restricted stock units from this grant.
LEMONIS MARCUS reported acquisition or exercise transactions in this Form 4 filing.
Bed Bath & Beyond, Inc. executive chairman and CEO Marcus Lemonis received a grant of 1,500,000 restricted stock units, each representing a contingent right to one share of common stock. The grant was approved by shareholders on May 14, 2026, after being originally granted on March 11, 2026.
The restricted stock units vest in four equal installments at the close of business on January 1, 2027, January 1, 2028, January 1, 2029, and January 1, 2030, with vested shares delivered promptly after each vesting date. Following this transaction, Lemonis is shown as beneficially owning 1,500,000 restricted stock units from this grant.
Dubois Lisa Foley reported acquisition or exercise transactions in this Form 4 filing.
Bed Bath & Beyond, Inc. Chief Operating Officer Lisa Foley Dubois received a grant of 227,273 restricted stock units, each representing one share of common stock. The RSUs were granted on April 2, 2026, subject to shareholder approval, which was obtained on May 14, 2026.
The award vests in four equal installments at the close of business on April 2, 2027, April 2, 2028, April 2, 2029, and April 2, 2030, with shares delivered promptly after each vesting date. Following this grant, she beneficially owns 227,273 RSUs from this award.
Dubois Lisa Foley reported acquisition or exercise transactions in this Form 4 filing.
Bed Bath & Beyond, Inc. Chief Operating Officer Lisa Foley Dubois received a grant of 227,273 restricted stock units, each representing one share of common stock. The RSUs were granted on April 2, 2026, subject to shareholder approval, which was obtained on May 14, 2026.
The award vests in four equal installments at the close of business on April 2, 2027, April 2, 2028, April 2, 2029, and April 2, 2030, with shares delivered promptly after each vesting date. Following this grant, she beneficially owns 227,273 RSUs from this award.
Sullivan Amy Ervin reported acquisition or exercise transactions in this Form 4 filing.
Bed Bath & Beyond, Inc. reported that its President, Amy Ervin Sullivan, received a grant of 454,545 restricted stock units, each representing one share of common stock. The RSUs were granted on April 2, 2026, subject to shareholder approval, which was obtained on May 14, 2026.
The RSUs vest in four equal installments at the close of business on April 2, 2027, April 2, 2028, April 2, 2029 and April 2, 2030, with vested shares delivered promptly after each vesting date. Following this grant, Sullivan beneficially owns 454,545 RSUs from this award.
Sullivan Amy Ervin reported acquisition or exercise transactions in this Form 4 filing.
Bed Bath & Beyond, Inc. reported that its President, Amy Ervin Sullivan, received a grant of 454,545 restricted stock units, each representing one share of common stock. The RSUs were granted on April 2, 2026, subject to shareholder approval, which was obtained on May 14, 2026.
The RSUs vest in four equal installments at the close of business on April 2, 2027, April 2, 2028, April 2, 2029 and April 2, 2030, with vested shares delivered promptly after each vesting date. Following this grant, Sullivan beneficially owns 454,545 RSUs from this award.
Bed Bath & Beyond, Inc. filed an amended current report to add detailed financial statements for The Brand House Collective (TBHC) and pro forma information for their completed merger. The amendment includes TBHC’s audited results for the three years ended January 31, 2026 and combined unaudited pro forma financials for the year ended December 31, 2025.
TBHC generated net sales of about $395.8 million in fiscal 2025 but reported a net loss of roughly $45.9 million and a shareholders’ deficit of about $53.9 million as of January 31, 2026. The notes describe significant related-party funding and revenue-sharing arrangements with Bed Bath & Beyond, including term loans and a collaboration agreement accounted for as debt, as well as a pending merger under which TBHC will become a wholly owned subsidiary.
Bed Bath & Beyond, Inc. filed an amended current report to add detailed financial statements for The Brand House Collective (TBHC) and pro forma information for their completed merger. The amendment includes TBHC’s audited results for the three years ended January 31, 2026 and combined unaudited pro forma financials for the year ended December 31, 2025.
TBHC generated net sales of about $395.8 million in fiscal 2025 but reported a net loss of roughly $45.9 million and a shareholders’ deficit of about $53.9 million as of January 31, 2026. The notes describe significant related-party funding and revenue-sharing arrangements with Bed Bath & Beyond, including term loans and a collaboration agreement accounted for as debt, as well as a pending merger under which TBHC will become a wholly owned subsidiary.
Bed Bath & Beyond, Inc. major-holder disclosure: Amplify Investments LLC and Amplify ETF Trust report beneficial ownership of 6,039,111 shares of Common Stock, representing 8.71% of the class as reported 03/31/2026. The filers state sole voting and dispositive power over these shares.
Bed Bath & Beyond, Inc. major-holder disclosure: Amplify Investments LLC and Amplify ETF Trust report beneficial ownership of 6,039,111 shares of Common Stock, representing 8.71% of the class as reported 03/31/2026. The filers state sole voting and dispositive power over these shares.
BED BATH & BEYOND, INC. filed an initial Form 3 for Chief Financial Officer Brian LaRose. This filing is a required statement of the executive’s beneficial ownership when he becomes a reporting insider. The data provided shows no reported purchases, sales, gifts, or other transactions.
BED BATH & BEYOND, INC. filed an initial Form 3 for Chief Financial Officer Brian LaRose. This filing is a required statement of the executive’s beneficial ownership when he becomes a reporting insider. The data provided shows no reported purchases, sales, gifts, or other transactions.